Effects of emotional response on adherence to antihypertensive medication and blood pressure improvement

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Keeley, Robert D ^a,b   Driscoll, Margaret ^c  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Driscoll Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; DIABETES MELLITUS; DOCTOR PATIENT RELATION; ELECTRONIC MEDICAL RECORD; EMOTION; FEMALE; GENDER; HEALTH BELIEF; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF CONCEPT; SEX DIFFERENCE; SOCIAL SUPPORT; SYSTOLIC BLOOD PRESSURE;

EID: 84874632143     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/358562     Document Type: Article

References (45)

1. WHO, Adherence to Long-Term Therapies: Evidence for Action 2003 Geneva, Switzerland World Health Organization
2. Pittman D. G., Tao Z., Chen W., Stettin G. D., Antihypertensive medication adherence and subsequent healthcare utilization and costs. American Journal of Managed Care 2010 16 8 568 576 2-s2.0-77956119855
3. Dimatteo M. R., Giordani P. J., Lepper H. S., Croghan T. W., Patient adherence and medical treatment outcomes: a meta-analysis. Medical Care 2002 40 9 794 811 2-s2.0-0036719562 10.1097/00005650-200209000-00009
4. Esposti L. D., Saragoni S., Benemei S., Batacchi P., Geppetti P., di Bari M., Marchionni N., Sturani A., Buda S., Esposti E. D., Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. ClinicoEconomics and Outcomes Research 2011 3 1 47 54 2-s2.0-79952910927 10.2147/CEOR.S15619
5. Kannel W. B., Dawber T. R., McGee D. L., Perspectives on systolic hypertension. The Framingham Study. Circulation 1980 61 6 1179 1182 2-s2.0-0018856859 (Pubitemid 10116256)
6. Ho P. M., Rumsfeld J. S., Masoudi F. A., McClure D. L., Plomondon M. E., Steiner J. F., Magid D. J., Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine 2006 166 17 1836 1841 2-s2.0-33749006625 10.1001/archinte.166.17.1836 (Pubitemid 44455165)
7. Heidenreich P. A., Patient adherence: the next frontier in quality improvement. American Journal of Medicine 2004 117 2 130 132 2-s2.0-3242697726 10.1016/j.amjmed.2004.03.007 (Pubitemid 38953735)
8. D M. R., Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care 2004 42 3 200 209 2-s2.0-1642397582 10.1097/01.mlr.0000114908.90348.f9
9. Osterberg L., Blaschke T., Adherence to medication. The New England Journal of Medicine 2005 353 5 487 497 2-s2.0-23044442340 10.1056/NEJMra050100 (Pubitemid 41127293)
10. Haynes R. B., Ackloo E., Sahota N., McDonald H. P., Yao X., Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008 2 CD000011 2-s2.0-44949230299
11. Steiner J. F., Ho P. M., Beaty B. L., Dickinson L. M., Hanratty R., Zeng C., Tavel H. M., Havranek E. P., Davidson A. J., Magid D. J., Estacio R. O., Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circulation 2009 2 5 451 457 2-s2.0-77649130108 10.1161/CIRCOUTCOMES.108.841635
12. Steiner J. F., Can we identify clinical predictors of medication adherence and should we? Medical Care 2010 48 3 193 195 2-s2.0-77649121209 10.1097/MLR.0b013e3181d51ddf
13. Keeley R. D., Davidson A. J., Crane L. A., Matthews B., Pace W., An association between negatively biased response to neutral stimuli and antidepressant nonadherence. Journal of Psychosomatic Research 2007 62 5 535 544 2-s2.0-34247365388 10.1016/j.jpsychores.2006.12.006 (Pubitemid 46635472)
14. Nau D. P., Aikens J. E., Pacholski A. M., Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gender Medicine 2007 4 3 205 213 2-s2.0-36048950234 10.1016/S1550-8579(07)80041-6 (Pubitemid 350082736)
15. Kraemer H. C., Frank E., Kupfer D. J., Moderators of treatment outcomes: clinical, research, and policy importance. Journal of the American Medical Association 2006 296 10 1286 1289 2-s2.0-33748647946 10.1001/jama.296.10.1286 (Pubitemid 44394901)
16. Kraemer H. C., Stice E., Kazdin A., Offord D., Kupfer D., How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry 2001 158 6 848 856 2-s2.0-0034977454 10.1176/appi.ajp.158.6.848 (Pubitemid 32547610)
17. Keeley R. D., Driscoll M., A moderator-mediator analysis of coronary heart disease mortality. Journal of Psychosomatic Research 2010 69 6 549 554 2-s2.0-78649444848 10.1016/j.jpsychores.2010.04.018
18. Steiner J. F., Prochazka A. V., The assessment of refill compliance using pharmacy records: methods, validity, and applications. Journal of Clinical Epidemiology 1997 50 1 105 116 2-s2.0-0031046049 10.1016/S0895-4356(96)00268-5 (Pubitemid 27089212)
19. Calvert S. B., Kramer J. M., Anstrom K. J., Kaltenbach L. A., Stafford J. A., Allen Lapointe N. M., Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. American Heart Journal 2012 163 4 657 665
20. Nesse R. M., Ellsworth P. C., Evolution, emotions, and emotional disorders. American Psychologist 2009 64 2 129 139 2-s2.0-61349193139 10.1037/a0013503
21. Ekman P., Friesen W. V., Emotion in the Human Face 1972 Elmsford, NY, USA Pergamon Publishing
22. Reker M., Ohrmann P., Rauch A. V., Kugel H., Bauer J., Dannlowski U., Arolt V., Heindel W., Suslow T., Individual differences in alexithymia and brain response to masked emotion faces. Cortex 2010 46 5 658 667 2-s2.0-77950461641 10.1016/j.cortex.2009.05.008
23. Seiferth N. Y., Pauly K., Habel U., Kellermann T., Jon Shah N., Ruhrmann S., Klosterkötter J., Schneider F., Kircher T., Increased neural response related to neutral faces in individuals at risk for psychosis. NeuroImage 2008 40 1 289 297 2-s2.0-38949201972 10.1016/j.neuroimage.2007.11.020
24. Jung C. G., Analytical Psychology: Its Theory and Practice 1968 New York, NY, USA Random House
25. Ekman P., An argument for basic emotions. Cognition Emotion 1992 6 169 200
26. Horne R., Weinman J., Hankins M., The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health 1999 14 1 1 24 2-s2.0-0033420462
27. Brown C., Battista D. R., Bruehlman R., Sereika S. S., Thase M. E., Dunbar-Jacob J., Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Medical Care 2005 43 12 1203 1207 2-s2.0-29444447093 10.1097/01.mlr.0000185733.30697.f6 (Pubitemid 43012177)
28. Khanderia U., Townsend K. A., Erickson S. R., Vlasnik J., Prager R. L., Eagle K. A., Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. Annals of Pharmacotherapy 2008 42 2 192 199 2-s2.0-39049134529 10.1345/aph.1K497 (Pubitemid 351238566)
29. De Weert-Van Oene G. H., De Jong C. A. J., Jörg F., Schrijvers G. J. P., The helping alliance questionnaire: psychometric properties in patients with substance dependence. Substance Use and Misuse 1999 34 11 1549 1569 2-s2.0-0344995269 (Pubitemid 29402432)
30. O'Hea E. L., Moon S., Grothe K. B., Boudreaux E., Bodenlos J. S., Wallston K., Brantley P. J., The interaction of locus of control, self-efficacy, and outcome expectancy in relation to HbA1c in medically underserved individuals with type 2 diabetes. Journal of Behavioral Medicine 2009 32 1 106 117 2-s2.0-58249108241 10.1007/s10865-008-9188-x
31. Bush T., Russo J., Ludman E., Lin E., Von Korff M., Simon G., Katon W., Walker: E., Perceived self-efficacy for depression self-management. A reliable and valid self-report measure with predictive validity. Proceedings of the American Psychological Society Meeting 2001 Toronto, Canada
32. Luszczynska A., Scholz U., Schwarzer R., The general self-efficacy scale: multicultural validation studies. Journal of Psychology 2005 139 5 439 457 2-s2.0-27844568564 (Pubitemid 41648925)
33. Jerusalem M., Schwarzer R., Schwarzer R., Self-efficacy as a resource factor in stress appraisal processes. Self-Efficacy: Thought Control of Action 1992 Washington, DC, USA Hemisphere 195 213
34. Ware J. E., Sherbourne C. D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992 30 6 473 483 2-s2.0-0026877917
35. D M. R., Social support and patient adherence to medical treatment: a meta-analysis. Health Psychology 2004 23 2 207 218 2-s2.0-1642365729 10.1037/0278-6133.23.2.207 (Pubitemid 38365280)
36. Fang J., Wylie-Rosett J., Cohen H. W., Kaplan R. C., Alderman M. H., Exercise, body mass index, caloric intake, and cardiovascular mortality. American Journal of Preventive Medicine 2003 25 4 283 289 2-s2.0-0242289629 10.1016/S0749-3797(03)00207-1 (Pubitemid 37346148)
37. Löwe B., Kroenke K., Gräfe K., Detecting and monitoring depression with a two-item questionnaire (PHQ-2). Journal of Psychosomatic Research 2005 58 2 163 171 2-s2.0-17044369113 10.1016/j.jpsychores.2004.09.006
38. D'Agostino R. B. Sr., Grundy S., Sullivan L. M., Wilson P., Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Journal of the American Medical Association 2001 286 2 180 187 2-s2.0-0034945516 (Pubitemid 32640849)
39. Guzder R. N., Gatling W., Mullee M. A., Mehta R. L., Byrne C. D., Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabetic Medicine 2005 22 5 554 562 2-s2.0-17844366883 10.1111/j.1464-5491.2005.01494.x (Pubitemid 40593130)
40. Kraemer H. C., Wilson G. T., Fairburn C. G., Agras W. S., Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002 59 10 877 883 2-s2.0-0036792805
41. Kraemer H. C., Lowe K. K., Kupfer D. J., To Your Health: How to Understand What Research Tells Us About Risk 2005 1 Oxford, UK Oxford University Press
42. Kraemer H. C., Blasey C. M., Centring in regression analyses: a strategy to prevent errors in statistical inference. International Journal of Methods in Psychiatric Research 2004 13 3 141 151 2-s2.0-4644287053 10.1002/mpr.170 (Pubitemid 39264454)
43. Katon W. J., Von Korff M., Lin E. H. B., Simon G., Ludman E., Russo J., Ciechanowski P., Walker E., Bush T., The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Archives of General Psychiatry 2004 61 10 1042 1049 2-s2.0-5044229591 10.1001/archpsyc.61.10.1042 (Pubitemid 39336538)
44. Pocock S. J., Assmann S. E., Enos L. E., Kasten L. E., Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statistics in Medicine 2002 21 19 2917 2930 2-s2.0-0037108235 10.1002/sim.1296
45. Kroenke K., Spitzer R. L., Williams J. B. W., The patient health questionnaire-2: validity of a two-item depression screener. Medical Care 2003 41 11 1284 1292 2-s2.0-0642311548 10.1097/01.MLR.0000093487.78664.3C